Abstract:Cancer is the most widely studied disorder in humans, but proper treatment has not yet been developed for it. Conventional therapies, like chemotherapy, radiation therapy, and surgery, have been employed. Such therapies target not only cancerous cells but also harm normal cells. Conventional therapy does not result in specific targeting and hence leads to severe side effects. The main objective of this study is to explore the QDs. QDs are used as nanocarriers for diagnosis and treatment at the same time. They are based on the principle of theranostic approach. QDs can be conjugated with antibodies via various methods that result in targeted therapy. This results in their dual function as a diagnostic and therapeutic tool. Nanotechnology involving such nanocarriers can increase the specificity and reduce the side effects, leaving the normal cells unaffected. This review pays attention to different methods for synthesising QDs. QDs can be obtained using either organic method and synthetic methods. It was found that QDs synthesised naturally are more feasible than the synthetic process. Top or bottom-up approaches have also emerged for the synthesis of QDs. QDs can be conjugated with an antibody via non-covalent and covalent binding. Covalent binding is much more feasible than any other method. Zero-length coupling plays an important role as EDC (1-Ethyl-3-Ethyl dimethylaminopropyl)carbodiimide is a strong crosslinker and is widely used for conjugating molecules. Antibodies work as surface ligands that lead to antigen- antibody interaction, resulting in site-specific targeting and leaving behind the normal cells unaffected. Cellular uptake of the molecule is done by either passive targeting or active targeting. QDs are tiny nanocrystals that are inorganic in nature and vary in size and range. Based on different sizes, they emit light of specific wavelengths. They have their own luminescent and optical properties that lead to the monitoring, imaging, and transport of the therapeutic moiety to a variety of targets in the body. The surface of the QDs is modified to boost their functioning. They act as a tool for diagnosis, imaging, and delivery of therapeutic moieties. For improved therapeutic effects, nanotechnology leads the cellular uptake of nanoparticles via passive targeting or active targeting. It is a crucial platform that not only leads to imaging and diagnosis but also helps to deliver therapeutic moieties to specific sites. Therefore, this review concludes that there are numerous drawbacks to the current cancer treatment options, which ultimately result in treatment failure. Therefore, nanotechnology that involves such a nanocarrier will serve as a tool for overcoming all limitations of the traditional therapeutic approach. This approach helps in reducing the dose of anticancer agents for effective treatment and hence improving the therapeutic index. QDs can not only diagnose a disease but also deliver drugs to the cancerous site.

Micro-UAV detection using DAB-based passive radar

Alloyed Geometric Structure Strategy Enables High-Quality Water-Soluble Quantum Dots for Ultrasensitive Fluorescence Immunoassay

Quantum Dot-Affibody Fluorescence Probes for Single Molecule Tracking in Living Cell Membranes

Multifunctional Effects Of Cys-Cdte Qds Conjugated With Gambogic Acid For Cancer Cell Tracing And Inhibition

Efficient drug delivery by polyethylenimine capped CdSe/ZnS quantum dots and their biological activity

N doped-carbon quantum dots with ultra-high quantum yield photoluminescent property conjugated with folic acid for targeted drug delivery and bioimaging applications

Synthesis, Biocompatibility and Cell Labeling of L-arginine-functional Beta-Cyclodextrin-modified Quantum Dot Probes.

Highly Luminescent and Biocompatible Near-Infrared Core–shell CdSeTe/CdS/C Quantum Dots for Probe Labeling Tumor Cells

Practical Aspects of the Integration of Agile Development and Model-driven Development: An Exploratory Study

Protective effect of nanoemulsions containing CdTe quantum dots with potential application as a diagnostic agent

The Biocompatibility of Quantum Dot Probes Used for the Targeted Imaging of Hepatocellular Carcinoma Metastasis.

Imaging of water soluble CdTe/CdS core-shell quantum dots in inhibiting multidrug resistance of cancer cells

Biocompatible Semiconductor Quantum Dots as Cancer Imaging Agents

Novel thymohydroquinone gallate derivative loaded ligand modified quantum dots as pH-sensitive multi-modal theragnostic agent for cancer treatment

Quantum Dot-based Bio-conjugates as an Emerging Bioimaging Tool for Cancer Theranostic- A Review

Therapeutic and Diagnostic Analysis of Cadmium Sulfide Quantum Dots Conjugated with Cysteine, Anticancer Drug and Folate

Abstract 5756: Silver graphene quantum dots as drug delivery platforms for anti-cancer application

Hybridized quantum dot, silica, and gold nanoparticles for targeted chemo-radiotherapy in colorectal cancer theranostics

Kinetic analysis of chloride efflux from normal and cystic fibrosis fibroblasts.

Theranostic Liposome–Nanoparticle Hybrids for Drug Delivery and Bioimaging

Synthesis, characterization, and pharmacological evaluation of dextrin capped cadmium sulfide quantum dots conjugated with temozolomide for drug delivery and imaging application